SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001144204-14-050788
Filing Date
2014-08-15
Accepted
2014-08-15 16:30:21
Documents
1
Period of Report
2014-08-13

Document Format Files

Seq Description Document Type Size
1 FORM 4 v386800_4.html 4  
1 FORM 4 v386800_4.xml 4 3173
  Complete submission text file 0001144204-14-050788.txt   4936
Mailing Address 2 SNUNIT ST SCIENCE PARK, POB 455 CARMIEL L3 20100
Business Address 2 SNUNIT ST SCIENCE PARK, POB 455 CARMIEL L3 20100 972-4-988-9488
Protalix BioTherapeutics, Inc. (Issuer) CIK: 0001006281 (see all company filings)

IRS No.: 650643773 | State of Incorp.: FL | Fiscal Year End: 1231
SIC: 2836 Biological Products, (No Diagnostic Substances)

Mailing Address MOSHE AVIV TOWER 7 ZABOTINSKY STREET RAMAT GAN L3 52520
Business Address MOSHE AVIV TOWER 7 ZABOTINSKY STREET RAMAT GAN L3 52520 972-3-611-4514
Bio-Cell Ltd (Reporting) CIK: 0001385114 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-33357 | Film No.: 141046846